“These are real savings that people will see right away,” a senior White House health official said. “This isn’t theoretical — these are price cuts negotiated directly with manufacturers.”
“For too long, the middlemen and special interests have driven up costs and rigged the system,” Trump said. “With TrumpRx, we’re putting patients — not the lobbyists — first.”
The Department of Health and Human Services said more than 40 manufacturers have already joined the TrumpRx platform, and more are expected in the coming weeks. Officials said the administration will prioritize adding high-impact treatments for chronic illnesses such as heart disease, asthma, cancer, and autoimmune disorders later this year.